Ocera Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 20   

Articles published

OCRX 5.80 +0.10 (1.75%)
price chart
Ocera Therapeutics Finally Ready To Reward Investors
Furthermore, to bluntly state the obvious, Ocera has had a rough 2014. Investors unfamiliar with the company would probably look at the stock chart and move on to the next assuming that something catastrophic had occurred to warrant such a steep price ...
Ocera Therapeutics to Present at 13th Annual BIO Investor Forum
PALO ALTO, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that company management will be ...
Related articles »  
Eye Catching Stocks: Ocera Therapeutics, Inc. (NASDAQ:OCRX), The Procter ...
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that Steven P. James has been appointed to the Company's Board of Directors.
Wet Seal Inc. (WTSL) is Top Small-Cap Star for October 1
Ocera Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need.
Related articles »  
Leading Small-Cap Stars Health Care Stock for October 17 Morning Session is ...
Ocera Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need.
Related articles »  
Leading Small-Cap Stars Health Care Stock for October 22 Morning Session is ...
Ocera Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need.
Related articles »  
Leading Health Care Stock for Small-Cap Stars is Tranzyme Inc (OCRX) for ...
Ocera Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need.
Ericsson Q2 Profit Rises, Sales Little Changed; Stock Falls
Net income attributable to stockholders of the parent company increased to 1.47 billion Swedish Kronor from last year's 1.11 billion kronor.
San Diego Stock Exchange
The San Diego Stock Exchange Index closed lower Wednesday at 159.33, down 1.20 percent from Tuesday. Declining issues beat advancers, 80-26, and 86 issues unchanged.
Related articles »  
Daily Digest
NuVasive Inc.: SEC documents showed Vice President Russell Powers exercised options on 3,750 shares at 0 dollars per share and surrendered 1,573 shares at $34.46 per share on Wednesday.
Related articles »